MUMBAI:
Clean Science and Technology Limited, a manufacturer of functionally critical specialty chemicals such as Performance Chemicals (i.e. MEHQ, BHA and AP), Pharmaceutical Intermediates (i.e. Guaiacol and DCC), and FMCG Chemicals (i.e. 4-MAP and Anisole) will open the Bid/Offer period in relation to its initial public offering of equity shares on 07 th July 2021 (the “IPO”/ “Offer”).The Price Band of the Offer has been fixed at Rs. 880 to Rs. 900 per Equity Share. Bids can be made for a minimum of 16 equity Shares and in multiples of 16 Equity Shares thereafter.
The Initial Public Offering will be an Offer for Sale aggregating up to Rs. 15,466.22 million, consisting of a sale of shares by Ashok Ramnarayan Boob aggregating up to Rs. 2,440.16 million, Krishnakumar Ramnarayan Boob aggregating up to Rs. 1,930.59 million, Siddhartha Ashok Sikchi up to Rs. 405.05 million, Parth Ashok Maheshwari aggregating up to Rs. 759.83 million. The Offer also includes a sale of shares by Asha Ashok Boob aggregating up to Rs. 2,440.16 million, Ashokkumar Ramkishan Sikchi HUF aggregating up to Rs. 1,360.51 million, Krishnakumar Ramnarayan Boob HUF aggregating up to Rs. 415.51 million, Ashok Ramnarayan Boob HUF aggregating up to Rs. 752.60 million, Nidhi Mohunta aggregating up to Rs. 759.83 million, Nilima Krishnakumar Boob aggregating up to Rs. 840.77 million, Shradha Krishnakumar Boob aggregating up to Rs. 440.28 million, Prasad Krishnakumar Boob aggregating up to Rs. 440.28 million, Pooja Vivek Navandar aggregating up to Rs. 440.28 million, Asha Ashok Sikchi aggregating up to Rs. Rs. 1,141.38 million, Kunal Ashok Sikchi aggregating up to Rs. 310.54 million, Ashok Sikchi aggregating up to Rs. 282.43 million, Nandita Sikchi aggregating up to Rs. 273.60 million, Ganapati Dadasaheb Yadav aggregating up to Rs. 32.42 million. The face value of equity shares is Rs. 1 each.
The Offer is being made through the Book Building Process, in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended (“SCRR”) read with Regulation 31 of the SEBI ICDR Regulations and in compliance with Regulation 6(1) of the SEBI ICDR Regulations, wherein not more than 50% of the Offer shall be allocated on a proportionate basis to Qualified Institutional Buyers (“QIBs”, the “QIB Portion”), provided that the
Company may, in consultation with the Book Running Lead Managers, allocate up to 60% of the QIB Portion to Anchor Investors on a discretionary basis in accordance with the SEBI ICDR Regulations (“Anchor Investor Portion”), of which one-third shall be reserved for domestic Mutual Funds, subject to valid Bids being received from domestic Mutual Funds at or above the Anchor Investor Allocation Price.
Further, 5% of the Net QIB Portion shall be available for allocation on a proportionate basis only to Mutual Funds, and the remainder of the Net QIB Portion shall be available for allocation on a proportionate basis to all QIBs, including Mutual Funds, subject to valid Bids being received at or above the Offer Price.
Further, not less than 15% of the Offer shall be available for allocation on a proportionate basis to Non-Institutional Bidders and not less than 35% of the Offer shall be available for allocation to Retail Individual Bidders (“RIBs”) in accordance with the SEBI ICDR Regulations, subject to valid Bids being received at or above the Offer Price. The Equity Shares offered through this Red Herring Prospectus are proposed to be listed on BSE and NSE.
Axis Capital Limited, JM Financial Limited and Kotak Mahindra Capital Company Ltd are the Book Running Lead Managers (“BRLMs”) to the Offer.
